These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 6744775

  • 1. Propafenone disposition kinetics in cardiac arrhythmia.
    Connolly S, Lebsack C, Winkle RA, Harrison DC, Kates RE.
    Clin Pharmacol Ther; 1984 Aug; 36(2):163-8. PubMed ID: 6744775
    [Abstract] [Full Text] [Related]

  • 2. Metabolite cumulation during chronic propafenone dosing in arrhythmia.
    Kates RE, Yee YG, Winkle RA.
    Clin Pharmacol Ther; 1985 Jun; 37(6):610-4. PubMed ID: 4006362
    [Abstract] [Full Text] [Related]

  • 3. Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart.
    Gillis AM, Kates RE.
    J Pharmacol Exp Ther; 1986 Jun; 237(3):708-12. PubMed ID: 3712276
    [Abstract] [Full Text] [Related]

  • 4. Investigations on the pharmacokinetics of propafenone in man.
    Hollmann M, Brode E, Hotz D, Kaumeier S, Kehrhahn OH.
    Arzneimittelforschung; 1983 Jun; 33(5):763-70. PubMed ID: 6683556
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacology of propafenone.
    Connolly SJ, Kates RE, Lebsack CS, Harrison DC, Winkle RA.
    Circulation; 1983 Sep; 68(3):589-96. PubMed ID: 6872170
    [Abstract] [Full Text] [Related]

  • 6. Lorcainide disposition kinetics in arrhythmia patients.
    Kates RE, Keefe DL, Winkle RA.
    Clin Pharmacol Ther; 1983 Jan; 33(1):28-34. PubMed ID: 6848296
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of propafenone: pharmacokinetics, metabolism and concentration-response relations.
    Siddoway LA, Roden DM, Woosley RL.
    Am J Cardiol; 1984 Nov 14; 54(9):9D-12D. PubMed ID: 6496371
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM, Kates RE.
    Clin Pharmacokinet; 1984 Nov 14; 9(5):375-403. PubMed ID: 6437721
    [Abstract] [Full Text] [Related]

  • 9. Disposition and antiarrhythmic effect of lorcainide.
    Klotz U, Müller-Seydlitz P, Heimburg P.
    Int J Clin Pharmacol Biopharm; 1979 Apr 14; 17(4):152-8. PubMed ID: 376458
    [Abstract] [Full Text] [Related]

  • 10. [Clinical pharmacology of propafenone].
    Ambrosioni E, Marchesini B.
    G Ital Cardiol; 1984 Apr 14; 14(4):285-92. PubMed ID: 6735021
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U, Müller-Seydlitz P, Heimburg P.
    Clin Pharmacokinet; 1978 Apr 14; 3(5):407-18. PubMed ID: 699462
    [Abstract] [Full Text] [Related]

  • 12. [Plasma level and effectiveness of propafenone and its organ distribution (author's transl)].
    Blanke H, Aschbrenner B, Karsch KR, Kreuzer H.
    Dtsch Med Wochenschr; 1979 Apr 20; 104(16):587-91. PubMed ID: 86416
    [No Abstract] [Full Text] [Related]

  • 13. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF, Agarwal JB, Weintraub WS, Bracchetti D, Helfant RH.
    G Ital Cardiol; 1984 Oct 20; 14(10):825-9. PubMed ID: 6519392
    [Abstract] [Full Text] [Related]

  • 14. [Oral propafenone in the long-term treatment of chronic ventricular arrhythmia].
    Vázquez García A, Marcos Sánchez F, Górgolas Hernández-Mora P, Durán Pérez-Navarro A.
    Rev Clin Esp; 1986 Jun 20; 179(2):101. PubMed ID: 3738054
    [No Abstract] [Full Text] [Related]

  • 15. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW, Rotem CE, Boroomand-Rashti K, Bar-Shlomo B.
    Can Med Assoc J; 1984 Sep 15; 131(6):601-3. PubMed ID: 6478345
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F, Disertori M, Vergara G, Guarnerio M, Dal Forno P, Padrini R, Gobbato S, Ferrari M.
    Int J Clin Pharmacol Res; 1983 Sep 15; 3(2):101-5. PubMed ID: 6679511
    [Abstract] [Full Text] [Related]

  • 17. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 15; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 18. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 15; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 19. [Oral propafenone in refractory arrhythmia. Apropos of 68 patients].
    Haissaguerre M, Wicker F, Goldrach S, Vrancea F, Regaudie JJ, Le Metayer P, Warin JF, Blanchot P.
    Ann Cardiol Angeiol (Paris); 1986 Mar 15; 35(3):173-9. PubMed ID: 3707020
    [Abstract] [Full Text] [Related]

  • 20. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M, Palma JL, Bayés de Luna A, Aza V, Sadurní J.
    Rev Esp Cardiol; 1984 Mar 15; 37(3):196-200. PubMed ID: 6505351
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.